Brief

The FDA updated its guidance on reviews of pediatric studies conducted under BPCA and pediatric assessments conducted under PREA from 2012 to present. The update aims to provide clarity on the requirements for submitting pediatric information, including the need for a clear and concise format for pediatric reports and the requirement for transparency in the review process.

This content is restricted.

Highlights content goes here...

This content is restricted.

Food and Drug Administration (FDA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies